Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients

Lung Center of Philippines, Manila

Tropical Disease Foundation, Manila

CHRU, Helen Joseph Hospital, Johannesburg

Case Western Reserve University, Kampala

PHRU, Tshepong Hospital, Klerksdorp

THINK, Pietermaritzburg

Enhancing Care Foundation, Durban

CHRU, King Dinuzulu, Durban

CHRU, Empilweni TB Hospital, Port Elizabeth

TASK, Cape Town

University of Cape Town Lung Institute, Cape Town

Moscow City Research and Practice Tuberculosis Treatment Centre, Moscow

Central TB Research Institute of the Federal Agency of Scientific Organizations, Moscow

Research Institute of Phthisiopulmonology of I. M. Sechenov First Moscow State Medical University, Moscow

Research Institute of the Phthisiopulmonology, Saint Petersburg

Ural Research Institute of Phthisiopulmonology, Yekaterinburg

Evandro Chagas, Rio de Janeiro

FIOCRUZ, Rio de Janeiro

Institut Perubatan Respiratori, Kuala Lumpur

Ifakara Health Institute, Bagamoyo

NIMR-Mbeya, Mbeya

Kilimanjaro Clinical Research Institute, Moshi

Mwanza Intervention Trials Unit, Mwanza

National Center for Tuberculosis and Lung Diseases, Tbilisi

Madibeng Centre for Research, Brits

Setshaba Research Centre, Soshanguve